XML 20 R9.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Oct. 01, 2021
Oct. 02, 2020
Statement of Cash Flows [Abstract]    
Net income $ 76,799 $ 11,656
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and other impairment charges 197,641 181,114
Stock-based compensation expense 26,235 21,642
Non-cash interest expense 3,757 4,253
Deferred income tax benefit (5,904) (30,946)
(Gain) loss on sale of property, plant and equipment (1,483) 523
Loss on debt extinguishment 29,870 0
Changes in operating assets and liabilities:    
Trade receivables, net (70,407) 44,592
Inventories, net (130,348) 28,556
Accounts payable 143,694 (42,869)
Other operating assets and liabilities (9,971) (45,388)
Net cash provided by operating activities 259,883 173,133
Cash flows from investing activities:    
Purchases of property, plant and equipment (73,595) (81,583)
Proceeds from sale of property, plant and equipment 2,908 4,929
Acquisitions, net of cash received, and investments (222,961) (7,477)
Net cash used in investing activities (293,648) (84,131)
Cash flows from financing activities:    
Payments under term credit facility 0 (40,000)
Proceeds from borrowings on revolving credit facilities and other 515,696 794,678
Repayments of borrowings on revolving credit facilities and other (409,961) (866,215)
Repayments of borrowings on senior notes (700,000) 0
Payment of debt issuance costs 0 (4,560)
Proceeds from issuance of common stock, net 738,177 2,930
Payment of debt extinguishment costs (24,375) 0
Deferred consideration payments and other (7,700) (12,411)
Net cash provided by (used in) financing activities 111,837 (125,578)
Effect of foreign exchange rates on Cash and cash equivalents and Restricted cash (1,659) (6,633)
Increase (decrease) in Cash and cash equivalents and Restricted cash 76,413 (43,209)
Cash and cash equivalents and Restricted Cash, beginning of period 101,069 109,632
Cash and cash equivalents, end of period 177,482 66,423
Supplemental disclosures of non-cash investing and financing activities:    
Common stock issued for acquisition, net of issuance costs $ 285,681 $ 0